Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionWealthcare Advisory Partners LLC
Latest Disclosed Ownership24,339 shares
Latest Disclosed Value $ 3,392,192
Wealthcare Advisory Partners LLC reports 24.52% increase in ownership of GILD / Gilead Sciences, Inc.

On April 14, 2026 - Wealthcare Advisory Partners LLC filed a 13F-HR form disclosing ownership of 24,339 shares of Gilead Sciences, Inc. (CH:GILD) valued at $3,392,192 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 19,547 shares of Gilead Sciences, Inc.. This represents a change in shares of 24.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 24,339 4,792 24.52 3,392 41.39 0.0660
2026-01-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 19,547 1,033 5.58 2,399 16.74 0.0471
2025-11-07 2025-09-30 13F GILEAD SCIENCES COM 375558103 18,514 -13 -0.07 2,055 0.05 0.0428
2025-07-22 2025-06-30 13F GILEAD SCIENCES COM 375558103 18,527 352 1.94 2,054 0.88 0.0469
2025-04-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 18,175 -88 -0.48 2,037 20.76 0.0546
2025-01-15 2024-12-31 13F GILEAD SCIENCES COM 375558103 18,263 2,229 13.90 1,687 25.45 0.0468
2024-11-04 2024-09-30 13F GILEAD SCIENCES COM 375558103 16,034 1,445 9.90 1,344 34.40 0.0383
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 14,589 913 6.68 1,001 -0.10 0.0313
2024-04-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 13,676 -419 -2.97 1,002 -12.27 0.0328
2024-02-06 2023-12-31 13F GILEAD SCIENCES COM 375558103 14,095 477 3.50 1,142 11.86 0.0454
2023-10-12 2023-09-30 13F GILEAD SCIENCES COM 375558103 13,618 -984 -6.74 1,021 -9.33 0.0469
2023-07-17 2023-06-30 13F GILEAD SCIENCES COM 375558103 14,602 -203 -1.37 1,125 -8.39 0.0503
2023-05-04 2023-03-31 13F GILEAD SCIENCES COM 375558103 14,805 -933 -5.93 1,228 -9.10 0.0528
2023-02-13 2022-12-31 13F GILEAD SCIENCES COMMON 375558103 15,738 3,404 27.60 1,351 77.53 0.0646
2022-11-14 2022-09-30 13F GILEAD SCIENCES COMMON 375558103 12,334 470 3.96 761 3.82 0.0434
2022-08-15 2022-06-30 13F GILEAD SCIENCES COMMON 375558103 11,864 11,864 733 0.0444
2022-04-15 2022-03-31 13F GILEAD SCIENCES COMMON 375558103 0 -3,070 -100.00 0 -100.00
2022-02-11 2021-12-31 13F GILEAD SCIENCES COMMON 375558103 3,070 -5,391 -63.72 223 -62.27 0.0133
2021-11-15 2021-09-30 13F GILEAD SCIENCES Equity 375558103 8,461 218 2.64 591 4.05 0.0386
2021-08-16 2021-06-30 13F GILEAD SCIENCES COMMON 375558103 8,243 -2,024 -19.71 568 -14.46 0.0380
2021-04-30 2021-03-31 13F GILEAD SCIENCES COMMON 375558103 10,267 5,497 115.24 664 138.85 0.0481
2021-02-12 2020-12-31 13F GILEAD SCIENCES COMMON 375558103 4,770 727 17.98 278 9.02 0.0247
2020-10-29 2020-09-30 13F GILEAD SCIENCES COMMON 375558103 4,043 4,043 255 0.0280
2020-07-29 2020-06-30 13F GILEAD SCIENCES COMMON 375558103 0 -2,205 -100.00 0 -100.00
2020-04-29 2020-03-31 13F GILEAD SCIENCES COMMON 375558103 2,205 -1,266 -36.47 165 -26.99 0.0242
2020-01-29 2019-12-31 13F GILEAD SCIENCES COMMON 375558103 3,471 1,282 58.57 226 62.59 0.0287
2019-10-16 2019-09-30 13F GILEAD SCIENCES COMMON 375558103 2,189 -61 -2.71 139 -8.55 0.0202
2019-07-30 2019-06-30 13F GILEAD SCIENCES COMMON 375558103 2,250 87 4.02 152 7.80 0.0241
2019-05-13 2019-03-31 13F GILEAD SCIENCES COMMON 375558103 2,163 4 0.19 141 4.44 0.0240
2019-02-14 2018-12-31 13F GILEAD SCIENCES COMMON 375558103 2,159 -63 -2.84 135 -21.51 0.0262
2018-11-14 2018-09-30 13F GILEAD SCIENCES COMMON 375558103 2,222 -208 -8.56 172 0.00 0.0316
2018-08-13 2018-06-30 13F GILEAD SCIENCES COMMON 375558103 2,430 -247 -9.23 172 -14.85 0.0337
2018-05-14 2018-03-31 13F GILEAD SCIENCES COMMON 375558103 2,677 -246 -8.42 202 -3.35 0.0456
2018-02-14 2017-12-31 13F GILEAD SCIENCES COMMON 375558103 2,923 1,284 78.34 209 57.14 0.0537
2017-11-15 2017-09-30 13F GILEAD SCIENCES COMMON 375558103 1,639 1,639 133 0.0395
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.